{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["4-Anilinoquinazoline", "Antifungal activity", "Antimicrobial activity", "Molecular docking", "Synthesis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "28974981", "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.4103/1735-5362.213988"], "Journal": {"ISSN": "1735-5362", "JournalIssue": {"Volume": "12", "Issue": "5", "PubDate": {"Year": "2017", "Month": "Oct"}}, "Title": "Research in pharmaceutical sciences", "ISOAbbreviation": "Res Pharm Sci"}, "ArticleTitle": "Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives.", "Pagination": {"StartPage": "425", "EndPage": "433", "MedlinePgn": "425-433"}, "Abstract": {"AbstractText": ["A series of novel 4-anilinoquinazoline derivatives were designed and synthesized from benzoic acid through ring closure, chlorination or nucleophilic substitution. The structures of compounds were characterized by IR, <sup>1</sup>H-NMR and mass spectroscopy. All synthesized derivatives were screened for their antimicrobial activities against Gram-positive (<i>Staphylococcus aurous</i>, <i>Bacillus subtilis</i>, <i>Listeria monocitogenes</i>) and Gram-negative (<i>Escherichia coli</i>, <i>Pseudomonas aeruginosa</i>, <i>Salmonella entritidis</i>) bacteria and also for antifungal activities against <i>Candida albicans</i> using the conventional micro dilution method. Most of the compounds have shown good antibacterial activities, especially compound <b>4c</b> having highest activities against <i>E. coli</i> at 32 \u03bcg/mL concentration while the tested compounds did not exhibited remarkable antifungal activities. The potential DNA gyrase inhibitory activity of these compounds was investigated <i>in silico</i> using molecular docking simulation method. All compounds showed good results especially compound <b>4c</b> which showed the lowest \u0394G<sub>bind</sub> results (-8.16 Kcal/mol)."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran."}], "LastName": "Nasab", "ForeName": "Rezvan Rezaee", "Initials": "RR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran."}], "LastName": "Hassanzadeh", "ForeName": "Farshid", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran."}], "LastName": "Khodarahmi", "ForeName": "Ghadam Ali", "Initials": "GA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran."}], "LastName": "Rostami", "ForeName": "Mahboubeh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran."}], "LastName": "Mirzaei", "ForeName": "Mahmoud", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biotechnology and Isfahan Pharmaceutical Sciences Research center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran."}], "LastName": "Jahanian-Najafabadi", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran."}], "LastName": "Mansourian", "ForeName": "Mahboubeh", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Res Pharm Sci", "NlmUniqueID": "101516968", "ISSNLinking": "1735-5362"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Gupta B, Singh S. Antibiotics-new tools in current and future drug therapy. Journal Of Scientific & Innovative Research. 2012;1(1):27\u201342."}, {"Citation": "Collin F, Karkare S, Maxwell A. Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. Appl Microbiol Biotechnol. 2011;92(3):479\u2013497.", "ArticleIdList": ["PMC3189412", "21904817"]}, {"Citation": "Ostrov DA, Prada JAH, Corsino PE, Finton KA, Le N, Rowe TC. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob Agents Chemother. 2007;51(10):3688\u20133698.", "ArticleIdList": ["PMC2043263", "17682095"]}, {"Citation": "Heddle J, Maxwell A. Quinolone-binding pocket of DNA gyrase: role of GyrB. Antimicrob Agents Chemother. 2002;46(6):1805\u20131815.", "ArticleIdList": ["PMC127264", "12019094"]}, {"Citation": "Kumar R, Madhumathi BS, Nagaraja V. Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase. Antimicrob Agents Chemother. 2014;58(4):2013\u20132020.", "ArticleIdList": ["PMC4023751", "24419347"]}, {"Citation": "Kumar A, Sharma P, Kumari P, Kalal BL. Exploration of antimicrobial and antioxidant potential of newly synthesized 2, 3-disubstituted quinazoline-4 (3H)-ones. Bioorg Med Chem Lett. 2011;21(14):4353\u20134357.", "ArticleIdList": ["21658941"]}, {"Citation": "Khodarahmi G, Jafari E, Hakimelahi G, Abedi D, Khajouei MR, Hassanzadeh F. Synthesis of some new quinazolinone derivatives and evaluation of their antimicrobial activities. Iran J Pharm Res. 2012;11(3):789\u2013797.", "ArticleIdList": ["PMC3813116", "24250506"]}, {"Citation": "Laddha SS, Wadodkar SG, Meghal SK. Studies on some biologically active substituted 4(3H)-quinazolinones. Part 1. Synthesis, characterization and anti-inflammatory#-antimicrobial activity$ of 6,8-disubstituted 2-phenyl-3-[substituted-benzothiazol-2-yl]-4(3H)-quinazolinones. ARKIVOC. 2006;Xi:1\u201320."}, {"Citation": "Abouzid K, Shouman S. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase. Bioorg. Med Chem. 2008;16(16):7543\u20137551.", "ArticleIdList": ["18678492"]}, {"Citation": "Jafari E, Khodarahmi G, Hakimelahi G, Tsai F, Hassanzadeh F. Synthesis of some new tricyclic 4 (3H)-quinazolinone derivatives. Res Pharm Sci. 2011;6(2):93\u2013100.", "ArticleIdList": ["PMC3249779", "22224092"]}, {"Citation": "Rezaee Nasab R, Karami B, Khodabakhshi S. Selective solvent-free biginelli condensation using Tungestat Sulfuric Acid as powerful and reusable catalyst. Bulletin of chemical reaction engineering& catalysis. 2014;9(2):148\u2013154."}, {"Citation": "Gilbert IH. Inhibitors of dihydrofolate reductase in Leishmania and trypanosomes. Biochim Biophys Acta. 2002;1587(2):249\u2013257.", "ArticleIdList": ["12084467"]}, {"Citation": "Jackman AL, Taylor GA, Gibson W, Kimbell R, Brown M, Calvert AH, et al. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res. 1991;51(20):5579\u20135586.", "ArticleIdList": ["1913676"]}, {"Citation": "Ismail RS, Ismail NS, Abuserii S, El Ella DAA. Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents. Future Journal of Pharmaceutical Sciences. 2016;2(1):9\u201319."}, {"Citation": "de Castro Barbosa ML, Lima LM, Tesch R, Sant'Anna CMR, Totzke F, Kubbutat MH, et al. Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors. Eur J Med Chem. 2014;71:1\u201314.", "ArticleIdList": ["24269511"]}, {"Citation": "Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J Med Chem. 2006;49(11):3315\u20133321.", "ArticleIdList": ["16722650"]}, {"Citation": "Jiang N, Zhai X, Zhao Y, Liu Y, Qi B, Tao H, et al. Synthesis and biological evaluation of novel 2-(2-arylmethylene) hydrazinyl-4-aminoquinazoline derivatives as potent antitumor agents. Eur J Med Chem. 2012;54:534\u2013541.", "ArticleIdList": ["22727449"]}, {"Citation": "Pawar VG, Sos ML, Rode HB, Rabiller M, Heynck S, Van Otterlo WA, et al. Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor. J Med Chem. 2010;53(7):2892\u20132901.", "ArticleIdList": ["20222733"]}, {"Citation": "Bansal S, Kumar S, Aggarwal V, Joseph A. Design, synthesis, docking study & antibacterial evaluation of 1, 3-diarylpyrazolyl substituted indolin-2-ones. Indo Global Journal of Pharmaceutical Sciences. 2014;4(1):1\u20137."}, {"Citation": "Jayashree B, Thomas S, Nayak Y. Design and synthesis of 2-quinolones as antioxidants and antimicrobials: a rational approach. Med Chem Res. 2010;19(2):193\u2013209."}, {"Citation": "Mansourian M, Fassihi A, Saghaie L, Madadkar-Sobhani A, Mahnam K, Abbasi M. QSAR and docking analysis of A2B adenosine receptor antagonists based on non-xanthine scaffold. Med Chem Res. 2015;24:394\u2013407."}, {"Citation": "Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 1998;19(14):1639\u20131662."}, {"Citation": "Jayalakshmi B, Raveesha K, Amruthesh K. Evaluation of antibacterial and antioxidant potential of Euphorbia cotinifolia linn.leaf extracts. Chem Ind Chem Eng Q. 2014;20(1):19\u201328."}, {"Citation": "Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature Protocols. 2008;3(2):163\u2013715.", "ArticleIdList": ["18274517"]}, {"Citation": "Baker CN, Banerjee SN, Tenover FC. Evaluation of Alamar colorimetric MIC method for antimicrobial susceptibility testing of Gram-negative bacteria. J Clin Microbiol. 1994;32(5):1261\u20131267.", "ArticleIdList": ["PMC263664", "8051254"]}, {"Citation": "Kampranis SC, Gormley NA, Tranter R, Orphanides G, Maxwell A. Probing the binding of coumarins and cyclothialidines to DNA gyrase. Biochemistry. 1999;38:1967\u20131976.", "ArticleIdList": ["10026280"]}, {"Citation": "Lewis RJ, Singh OMP, Smith CV, Skarzynski T, Maxwell A, Wonacott AJ, et al. The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography. EMBO J. 1996;15:1412\u20131420.", "ArticleIdList": ["PMC450046", "8635474"]}, {"Citation": "Blance SJ, Williams NL, Preston ZA, Bishara J, Smyth MS, Maxwell A. Temperature-sensitive suppressor mutations of the Escherichia coli DNA gyrase B protein. Protein Sci. 2000;9(5):1035\u20131037.", "ArticleIdList": ["PMC2144630", "10850814"]}, {"Citation": "Boyapati S, Kulandaivelu U, Sangu S, Vanga MR. Synthesis, antimicrobial evaluation, and docking studies of novel 4-substituted quinazoline derivatives as DNA-gyrase inhibitors. Archiv der Pharmazie. 2010;343(10):570\u2013576.", "ArticleIdList": ["20941729"]}, {"Citation": "Mladenovic M, Vukovic N, Sukdolak S, Solujic S. Design of novel 4-hydroxy-chromene-2-one derivatives as antimicrobial agents. Molecules. 2010;15(6):4294\u20134308.", "ArticleIdList": ["PMC6257651", "20657442"]}, {"Citation": "Perumal P, Pandey VP, Parasuraman P. Docking studies on some novel piperidine analogues against DNA gyrase enzyme. Inventi Rapid Molecular Modeling. 2014;1:1\u20134."}, {"Citation": "Patil RB, Sawant SD. Synthesis, characterization, molecular docking and evaluation of antimicrobial activity of some 3-heteroaryl substituted chromen-2-one derivatives. Int J Pharm Tech Res 2014. 2015;7(3):471\u2013480."}, {"Citation": "Salih NA. Synthesis of some new quinazolin-4 (3h)- one derivatives and study of their some antibacterial activity. Journal of Al-Nahrain University. 2008;11(2):16\u201323."}, {"Citation": "Li F, Feng Y, Meng Q, Li W, Li Z, Wang Q, et al. An efficient construction of quinazolin-4 (3H)-ones under microwave irradiation. Arkivoc. 2007;1:40\u201350."}, {"Citation": "Arnott EA, Chan LC, Cox BG, Meyrick B, Phillips A. POCl3 chlorination of 4-quinazolones. J Org Chem. 2011;76(6):1653\u20131661.", "ArticleIdList": ["21294532"]}, {"Citation": "El-Azab AS, Al-Omar MA, Alaa A-M, Abdel-Aziz NI, Magda A-A, Aleisa AM, et al. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study. Eur J Med Chem. 2010;45(9):4188\u20134198.", "ArticleIdList": ["20599299"]}, {"Citation": "Van Horn KS, Burda WN, Fleeman R, Shaw LN, Manetsch R. Antibacterial activity of a series of N 2, N 4-disubstituted quinazoline-2, 4-diamines. J Med Chem. 2014;57(7):3075\u20133093.", "ArticleIdList": ["24625106"]}, {"Citation": "Gottasov\u00e1 R, Kubikov\u00e1 J. Antibacterial effect of some 2, 6-disubstituted 4-anilinoquinazolines. Folia Microbiologica. 1998;43(6):679\u2013682.", "ArticleIdList": ["10189231"]}, {"Citation": "Parhi AK, Zhang Y, Saionz KW, Pradhan P, Kaul M, Trivedi K, et al. Antibacterial activity of quinoxalines, quinazolines, and 1, 5-naphthyridines. Bioorg Med Chem Lett. 2013;23(17):4968\u20134974.", "ArticleIdList": ["PMC3947850", "23891185"]}]}], "History": [{"Year": "2017", "Month": "10", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "5", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "10", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28974981", "PMC5615873", "10.4103/1735-5362.213988", "RPS-12-425"]}}]}